Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation

Craig S. Sauter, Lauren Lechner, Michael Scordo, Junting Zheng, Sean M. Devlin, Stephen E. Fleming, Hugo Castro-Malaspina, Craig Moskowitz

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Whether chemosensitivity, as determined by positron emission tomography using fluorine-18-deoxyglucose (FDG-PET), is a requirement for successful allogeneic hematopoietic stem cell transplantation (allo-SCT) has yet to be established. We analyzed 88 patients with B cell non-Hodgkin lymphoma (B-NHL) for event-free (EFS) and overall survival (OS) according to computed tomography (CT) and FDG-PET criteria before uniform nonmyeloablative (NMA) allo-SCT. Patients who were chemosensitive, according to CT criteria, experienced significantly greater EFS (P < .001) and OS (P < .03) compared with those who were chemorefractory at the time of allo-SCT. Of 58 patients within this cohort who were chemosensitive by CT criteria, there was no difference in EFS (P = .85) or OS (P = .96) between FDG-PET-positive (Deauville 4 to 5, n = 24) and FDG-PET-negative (Deauville 1 to 3, n = 34) patients. There was no difference in survival according to age < or ≥ 60 years, prior autologous-stem cell transplantation, allograft characteristics, or histology. FDG-PET adds no prognostic value in chemosensitive B-NHL before NMA-allo-SCT.

Original languageEnglish (US)
Pages (from-to)881-884
Number of pages4
JournalBiology of Blood and Marrow Transplantation
Volume20
Issue number6
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Fluorine
Hematopoietic Stem Cell Transplantation
Deoxyglucose
Stem Cell Transplantation
B-Cell Lymphoma
Positron-Emission Tomography
Non-Hodgkin's Lymphoma
Survival
Tomography
Allografts
Histology

Keywords

  • Allogeneic transplant
  • B cell non-Hodgkin lymphoma
  • Fluorine-18-deoxyglucose-Positron emission tomography (FDG-PET) scan

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation. / Sauter, Craig S.; Lechner, Lauren; Scordo, Michael; Zheng, Junting; Devlin, Sean M.; Fleming, Stephen E.; Castro-Malaspina, Hugo; Moskowitz, Craig.

In: Biology of Blood and Marrow Transplantation, Vol. 20, No. 6, 01.01.2014, p. 881-884.

Research output: Contribution to journalArticle

@article{272df94c98e641f4952870d08e064576,
title = "Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation",
abstract = "Whether chemosensitivity, as determined by positron emission tomography using fluorine-18-deoxyglucose (FDG-PET), is a requirement for successful allogeneic hematopoietic stem cell transplantation (allo-SCT) has yet to be established. We analyzed 88 patients with B cell non-Hodgkin lymphoma (B-NHL) for event-free (EFS) and overall survival (OS) according to computed tomography (CT) and FDG-PET criteria before uniform nonmyeloablative (NMA) allo-SCT. Patients who were chemosensitive, according to CT criteria, experienced significantly greater EFS (P < .001) and OS (P < .03) compared with those who were chemorefractory at the time of allo-SCT. Of 58 patients within this cohort who were chemosensitive by CT criteria, there was no difference in EFS (P = .85) or OS (P = .96) between FDG-PET-positive (Deauville 4 to 5, n = 24) and FDG-PET-negative (Deauville 1 to 3, n = 34) patients. There was no difference in survival according to age < or ≥ 60 years, prior autologous-stem cell transplantation, allograft characteristics, or histology. FDG-PET adds no prognostic value in chemosensitive B-NHL before NMA-allo-SCT.",
keywords = "Allogeneic transplant, B cell non-Hodgkin lymphoma, Fluorine-18-deoxyglucose-Positron emission tomography (FDG-PET) scan",
author = "Sauter, {Craig S.} and Lauren Lechner and Michael Scordo and Junting Zheng and Devlin, {Sean M.} and Fleming, {Stephen E.} and Hugo Castro-Malaspina and Craig Moskowitz",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2014.02.009",
language = "English (US)",
volume = "20",
pages = "881--884",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation

AU - Sauter, Craig S.

AU - Lechner, Lauren

AU - Scordo, Michael

AU - Zheng, Junting

AU - Devlin, Sean M.

AU - Fleming, Stephen E.

AU - Castro-Malaspina, Hugo

AU - Moskowitz, Craig

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Whether chemosensitivity, as determined by positron emission tomography using fluorine-18-deoxyglucose (FDG-PET), is a requirement for successful allogeneic hematopoietic stem cell transplantation (allo-SCT) has yet to be established. We analyzed 88 patients with B cell non-Hodgkin lymphoma (B-NHL) for event-free (EFS) and overall survival (OS) according to computed tomography (CT) and FDG-PET criteria before uniform nonmyeloablative (NMA) allo-SCT. Patients who were chemosensitive, according to CT criteria, experienced significantly greater EFS (P < .001) and OS (P < .03) compared with those who were chemorefractory at the time of allo-SCT. Of 58 patients within this cohort who were chemosensitive by CT criteria, there was no difference in EFS (P = .85) or OS (P = .96) between FDG-PET-positive (Deauville 4 to 5, n = 24) and FDG-PET-negative (Deauville 1 to 3, n = 34) patients. There was no difference in survival according to age < or ≥ 60 years, prior autologous-stem cell transplantation, allograft characteristics, or histology. FDG-PET adds no prognostic value in chemosensitive B-NHL before NMA-allo-SCT.

AB - Whether chemosensitivity, as determined by positron emission tomography using fluorine-18-deoxyglucose (FDG-PET), is a requirement for successful allogeneic hematopoietic stem cell transplantation (allo-SCT) has yet to be established. We analyzed 88 patients with B cell non-Hodgkin lymphoma (B-NHL) for event-free (EFS) and overall survival (OS) according to computed tomography (CT) and FDG-PET criteria before uniform nonmyeloablative (NMA) allo-SCT. Patients who were chemosensitive, according to CT criteria, experienced significantly greater EFS (P < .001) and OS (P < .03) compared with those who were chemorefractory at the time of allo-SCT. Of 58 patients within this cohort who were chemosensitive by CT criteria, there was no difference in EFS (P = .85) or OS (P = .96) between FDG-PET-positive (Deauville 4 to 5, n = 24) and FDG-PET-negative (Deauville 1 to 3, n = 34) patients. There was no difference in survival according to age < or ≥ 60 years, prior autologous-stem cell transplantation, allograft characteristics, or histology. FDG-PET adds no prognostic value in chemosensitive B-NHL before NMA-allo-SCT.

KW - Allogeneic transplant

KW - B cell non-Hodgkin lymphoma

KW - Fluorine-18-deoxyglucose-Positron emission tomography (FDG-PET) scan

UR - http://www.scopus.com/inward/record.url?scp=84899912390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899912390&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2014.02.009

DO - 10.1016/j.bbmt.2014.02.009

M3 - Article

C2 - 24534109

AN - SCOPUS:84899912390

VL - 20

SP - 881

EP - 884

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 6

ER -